Method for detecting procoagulant conditions
CA 2461617 A1 · Owner: Berg, Lois Hill · Inventors: Berg, Lois Hill; Berg, David E.; Harrison, Harold H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for detecting, treating, and monitoring conditions associated with activation of the coagulation response such as chronic fatigue syndrome and , fibromyalgia by evaluating the status of the coagulation response in a patient by using a novel combination of tests which can detect minimal activation of the coagulation response in a patient. The novel combination includes tests for determining levels of fibrinogen prothrombin fragment 1 + , 2, thrombin/antithrombin complexes soluble fibrin monomer, and platelet , activation by flow cytometry. These assays are highly sensitive to minimal deviation from normal. Deviation from the normal values in any two of the five assays permits …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 19, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 19, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.